Midodrine
From Wikipedia, the free encyclopedia
 |
|
|
Midodrine
|
|
| Systematic (IUPAC) name | |
| 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]-acetamide | |
| Identifiers | |
| CAS number | |
| ATC code | C01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C12H18N2O4 |
| Mol. mass | 254.282 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Midodrine is an alpha-sympathomimetic drug. It is used to treat hepatorenal syndrome and orthostatic hypotension. It is not given before bedtime to avoid supine hypertension; the last dose of midodrine should be taken at least 3 to 4 hours before bedtime.
[edit] External links
- Hebenstreit G. Treatment of hypotension caused by psychopharmacological drugs (in German). Wien Med Wochenschr 1981;131:109-12. PMID 6165144.
|
|||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
